XML 17 R4.htm IDEA: XBRL DOCUMENT v3.22.1
Unaudited Consolidated Statements of Operations and Comprehensive Income - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Mar. 31, 2022
Mar. 31, 2021
Revenues:        
Recurring and other revenue $ 244,962 $ 184,927 $ 620,827 $ 465,195
Interest income on funds held for clients 1,008 1,126 2,877 2,981
Total revenues 245,970 186,053 623,704 468,176
Cost of revenues 75,538 57,326 209,608 160,248
Gross profit 170,432 128,727 414,096 307,928
Operating expenses:        
Sales and marketing 52,752 40,055 154,856 115,504
Research and development 25,670 18,458 74,024 56,443
General and administrative 44,632 31,071 119,448 87,038
Total operating expenses 123,054 89,584 348,328 258,985
Operating income 47,378 39,143 65,768 48,943
Other expense (311) (207) (800) (843)
Income before income taxes 47,067 38,936 64,968 48,100
Income tax expense (benefit) 12,221 2,102 (10,663) (10,836)
Net income 34,846 36,834 75,631 58,936
Other comprehensive loss, net of tax (1,218) (126) (1,628) (536)
Comprehensive income $ 33,628 $ 36,708 $ 74,003 $ 58,400
Net income per share:        
Basic (in dollars per share) $ 0.63 $ 0.68 $ 1.38 $ 1.09
Diluted (in dollars per share) $ 0.62 $ 0.65 $ 1.34 $ 1.05
Weighted-average shares used in computing net income per share:        
Basic (in shares) 55,114 54,415 54,996 54,244
Diluted (in shares) 56,367 56,414 56,437 56,338